Speakers

Jason Acker

Professor, Laboratory Medicine and Pathology

University of Alberta, Canada

Jennifer Adrian

Manager, Cellular Therapy Manufacturing Operations

bluebird bio

Carlton Anderson

COO

Ambulero

Priya Baraniak

Vice President, Corporate Development

Organobio

Thomas Bollenbach

Chief Technology Officer

Advanced Regenerative Manufacturing Institute

Sofia Braag

Business Development Principal

University of Massachusetts Medical School

Christopher Bravery

Director

Consulting on Advanced Biologicals Ltd., Member, ISCT EU Legal and Regulatory Affairs Committee, UK

Jennifer Briggs Braswell, PhD

Chief Administrative Officer

ARMI, BioFab, USA

Scott Burger

Principal

Advanced Cell & Gene Therapy, USA

Erica Bust

Senior Process Engineer

Juno Therapeutics Inc., USA

Phillip D. Carter

Head of U.S. Market Access

Orchard Therapeutics

Veeren Chauhan

Nottingham Research Fellow in Bio-inspired Therapeutics in the Advanced Materials & Healthcare Technologies

University of Nottingham

Kathryn Corzo

Head of Development Oncology Cell Therapies

Takeda

Jennifer L. Dashnau

Head of Analytical Development and Quality Control

Century Therapeutics, USA

Anthony Davies, Ph.D.

Founder & CEO

Dark Horse Consulting

Michael J. DiBiasio-White, Sr.

Scientist: BioProcess Development/Protein Sciences

Ring Therapeutics

David Dobnik

Scientific Associate

National Institute of Biology, Slovenia

Mehmet Dokmeci

Adjunct Professors

University of California (UCLA)

Andrew Espejo

Vector Analytics Lead, CMC Gene Therapy

Vertex Pharmaceuticals (pending final confirmation)

Allen Feng

Chief Scientific Officer

HebeCell Corp., USA

Miguel Forte

CEO

Bone Therapeutics, Belgium

Michael Francis

Chief Scientific Officer - Co-Founder

Embody, Faculty at EVMS

Mike Fraser

General Manager of EMEA

AveXis Inc., Switzerland

Benjamin Fryer

Founder

Pluristyx, Incorporated, USA

Chris Gemmiti, Ph.D.

Head of Operations

Sentien Biotechnologies Inc.

Jennifer Griffin

VP Industrial Strategy & Investments

Massachusetts Life Science Center

Adam Haskett

Associate Director, External Manufacturing

Kite Pharma

Geoffrey Hodge

Chief Technical Officer

Unum Therapeutics

Barrett J. Nehila

Associate Director, Analytical Development

Torque Therapeutics

Deepak Jain

COO

Twin City Bio

Scott Jeffers

Director

UniQure

Jan Jensen

CEO and Founder

Trailhead Biosystems Inc.

George Joseph Christ

Professor of Biomedical Engineering and Orthopaedic Surgery

University of Virginia

Vadim Klyushnichenko

VP Pharmaceutical Development and Quality

Calibr at Scripps Research

Jak Knowles

VP Venture Investments

Bayer

Mrignayani Kotecha

Co-Founder, CEO

O2M Technologies

Walter Kowtonuik

Principal

Third Rock Ventures, USA

Thomas Kreil

Vice President, Global Pathogen Safety

Takeda

Paul Lammers

President & CEO

Triumvira Immunologics

Philip Lee

COO and Co-Founder

Senti Biosciences

Sara Levy

CSV & Data integrity Manager

Pluristem Therapeutics Inc.

John Lewis Ph.D.

Co-founder and CEO, Aegis Life Inc.,

Entos Pharmaceuticals, CA

Janet Lynch Lambert

Chief Executive Officer

Alliance for Regenerative Medicine, USA

Joey Mason

Head of the Life Sciences Fund

M Ventures, The Netherlands

Kevin W. Mayo

Managing Partner

Venture Genome LLC

Mary Clare McCorry

Director, Technology and Process Development

Advanced Regenerative Manufacturing Institute (ARMI)

David McKenna

Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology

University of Minnesota

Ali Mohamed

VP, CMC

Immatics, USA

Mustafa Munye

Lead Scientist

Cell and Gene Therapy Catapult

Christiane Niederlaender

Director, AMBR Consulting Ltd

formerly MHRA, UK

Nicole Nuñez, Ph.D.,

Process Development Scientist

Eureka Therapeutics, Inc.

John O'Neill

Co-Founder & Chief Scientific Officer

Xylyx Bio, Inc.

Racheli Ofir

Vice President Research & Intellectual Property

Pluristem Therapeutics Inc., Israel

Steve Oh

Director Stem Cell Bioprocessing & Institute Professor,

Bioprocessing Technology Institute

Philippe Parone

Industrialisation Lead

Celyad, Belgium

Shyam Patel

Director Business Development

California Institute for Regenerative Medicine

Kai Pinkernell

Chief Medical Officer (CMO) & Chief Development Officer

Medigene

Alison Quelch

Director, Talent Acquisition, Global Product Development & Supply

Bristol-Myers Squibb

Mahendra Rao

CEO

panCELLa

Lior Raviv

Vice President

Pluristem Therapeutics Inc.

Betsy Rezner

Director, Process & Assay Development

Fate Therapeutics Inc.

Camillo Ricordi

Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow

National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA

Andrew Rigoglioso

Associate Director, Talent Acquisition

Flagship Pioneering

Michael Roberts

Chief Technology Officer (Europe)

Asklepios BioPharmaceutical, Inc.

Martha Rook

SVP, Manufacturing

Sigilon Therapeutics Inc.

Jon A. Rowley, Ph.D.

Founder & Chief Product Officer

RoosterBio Inc.

Jennifer Royal-Fitch

Lead Recruiter

Gene Therapy Program & The Orphan Disease Center, Univeristy of Pennsylvania

Gregory Russotti

Chief Technology Officer

Century Therapeutics LLC, USA

Janelle A. Sabo

Global Head, Clinical Supplies, Systems and Innovation

Eli Lilly Research and Development

Dominic Schmidt

Partner

Syncona Investment Management Ltd., UK

Franz Schnetzinger

Director Analytical Development

Gyroscope Therapeutics

Elizabeth Schwarzbach

CBO

New York Stem Cell Foundation

Margarida Serra

Head of Stem Cell Bioengineering Lab

iBET - Instituto de Biologia Experimental e Tecnológica

Sha Sha

Postdoc

Massachusetts Institute of Technology

Lara Ionescu Silverman

Senior Director, Research and Development

DiscGenics

Donald Singer

Consultant

formerly, GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations, USA

David Smith

Chief Commercial Officer

Healios

Devyn Smith

Chief Strategy Officer and Head of Operations

Sigilon Therapeutics, USA

Nick Timmins

VP Cell Technologies and Entrepreneur in Residence

ArtisanBio, USA

Sam Wadsworth

Chief Scientific Officer

Ultragenyx Gene Therapy

Tom Walls

Associate Director Supply Chain

bluebirdbio

Jason Walsh

Chief Financial Officer

GPB SCIENTIFIC, LLC

Kathy Williams

VP of Quality and Reg Affairs

RoosterBio, Inc., USA

Erik Woods

Co-Founder and Chief Science Officer

Ossium Health, Inc., USA

Rachel Yost

Senior Process Engineer

Juno Therapeutics Inc.

Mike Zhao

Senior Vice President

MSQ Ventures

Mike Zhao

Senior Vice President

MSQ Ventures

Qin Zou, Ph.D.

Senior Principal Scientist

Pfizer